IGC Pharma, Inc. (IGC)

IGC Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.11	0.41	1.2	3.2	10.46	14.55
Short-Term Investments	0.03	-	-	0.15	-	0.08
Cash & Short-Term Investments	1.13	0.41	1.2	3.35	10.46	14.63
Cash Growth	-26.91%	-66.19%	-64.24%	-67.97%	-28.49%	18.55%
Accounts Receivable	0.04	0.03	0.04	0.11	0.13	0.18
Other Receivables	0.02	0.04	0.05	0.02	0.47	0.05
Receivables	0.06	0.08	0.09	0.13	0.6	0.22
Inventory	0.66	1.36	1.54	2.65	3.55	7.18
Prepaid Expenses	0.13	0.34	0.12	0.26	0.17	0.16
Other Current Assets	0.03	0.71	0.76	0.07	0.34	1.33
Total Current Assets	2	2.9	3.71	6.47	15.11	23.52
Property, Plant & Equipment	2.19	3.32	3.89	8.54	9.87	11.33
Long-Term Investments	-	-	-	-	-	0.01
Other Intangible Assets	4.88	1.85	1.62	1.17	0.92	0.41
Other Long-Term Assets	0.67	0.68	0.69	1	0.94	0.6
Total Assets	9.74	8.75	9.9	17.18	26.83	35.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Accounts Payable	0.63	0.88	0.77	0.53	0.98	0.48
Accrued Expenses	0.54	0.28	1.02	0.88	1.21	1.18
Current Portion of Long-Term Debt	-	-	-	-	0	0.3
Current Portion of Leases	0.01	0.09	0.12	0.13	0.12	0.09
Other Current Liabilities	0.33	1	0.42	0.36	0.12	0.32
Total Current Liabilities	1.51	2.26	2.34	1.9	2.44	2.37
Long-Term Debt	0.13	0.13	0.14	0.14	0.14	0.28
Long-Term Leases	0.01	0.01	0.08	0.21	0.34	0.41
Pension & Post-Retirement Benefits	-	0.02	0.02	0.02	0.02	0.02
Total Liabilities	1.65	2.42	2.58	2.27	2.94	3.06

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Common Stock	135.77	130.57	124.41	118.97	116.02	109.72
Retained Earnings	-122.83	-120.74	-113.67	-100.67	-89.16	-74.14
Comprehensive Income & Other	-4.85	-3.5	-3.42	-3.39	-2.97	-2.77
Total Common Equity	8.09	6.33	7.32	14.91	23.89	32.8
Shareholders' Equity	8.09	6.33	7.32	14.91	23.89	32.8
Total Liabilities & Equity	9.74	8.75	9.9	17.18	26.83	35.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Total Debt	0.15	0.24	0.35	0.48	0.61	1.08
Net Cash (Debt)	0.98	0.17	0.85	2.87	9.85	13.55
Net Cash Growth	-20.77%	-80.42%	-70.27%	-70.87%	-27.33%	15.69%
Net Cash Per Share	0.01	0.00	0.01	0.05	0.20	0.32
Filing Date Shares Outstanding	92.87	83.89	75.64	53.08	51.74	48.33
Total Common Shares Outstanding	91.96	80.88	66.69	53.08	51.05	47.83
Working Capital	0.49	0.64	1.37	4.57	12.67	21.15
Book Value Per Share	0.09	0.08	0.11	0.28	0.47	0.69
Tangible Book Value	3.21	4.48	5.71	13.74	22.98	32.4
Tangible Book Value Per Share	0.03	0.06	0.09	0.26	0.45	0.68
Land	-	-	-	4.1	4.44	4.61
Buildings	1.5	2.34	2.3	2.3	2.81	3.82
Machinery	2.38	3.57	3.83	3.75	5.28	5.2
Construction In Progress	-	-	-	-	0.11	0.05

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error